Page last updated: 2024-08-18

quinuclidines and cp 31398

quinuclidines has been researched along with cp 31398 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Califano, JA; Kang, SK; Koch, WM; Minn, I; Roh, JL; Sidransky, D	1
Omar, SI; Tuszynski, J	1

Other Studies

2 other study(ies) available for quinuclidines and cp 31398

Article	Year
p53-Reactivating small molecules induce apoptosis and enhance chemotherapeutic cytotoxicity in head and neck squamous cell carcinoma. Oral oncology, 2011, Volume: 47, Issue:1 Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Combined Modality Therapy; Drug Screening Assays, Antitumor; Female; Furans; Genetic Therapy; Head and Neck Neoplasms; Humans; Imidazoles; Male; Piperazines; Pyrimidines; Quinuclidines; Tumor Suppressor Protein p53	2011
Ranking the Binding Energies of p53 Mutant Activators and Their ADMET Properties. Chemical biology & drug design, 2015, Volume: 86, Issue:2 Topics: Alkylation; Amifostine; Aza Compounds; Bridged Bicyclo Compounds, Heterocyclic; Drug Evaluation, Preclinical; Ellipticines; Heterocyclic Compounds, 4 or More Rings; Humans; Kinetics; Ligands; Mercaptoethylamines; Molecular Dynamics Simulation; Mutagenesis, Site-Directed; Mutation; Oxepins; Protein Binding; Pyrimidines; Quinuclidines; Tumor Suppressor Protein p53	2015

Article

Year

p53-Reactivating small molecules induce apoptosis and enhance chemotherapeutic cytotoxicity in head and neck squamous cell carcinoma.

Oral oncology, 2011, Volume: 47, Issue:1

Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Combined Modality Therapy; Drug Screening Assays, Antitumor; Female; Furans; Genetic Therapy; Head and Neck Neoplasms; Humans; Imidazoles; Male; Piperazines; Pyrimidines; Quinuclidines; Tumor Suppressor Protein p53

2011

Ranking the Binding Energies of p53 Mutant Activators and Their ADMET Properties.

Chemical biology & drug design, 2015, Volume: 86, Issue:2

Topics: Alkylation; Amifostine; Aza Compounds; Bridged Bicyclo Compounds, Heterocyclic; Drug Evaluation, Preclinical; Ellipticines; Heterocyclic Compounds, 4 or More Rings; Humans; Kinetics; Ligands; Mercaptoethylamines; Molecular Dynamics Simulation; Mutagenesis, Site-Directed; Mutation; Oxepins; Protein Binding; Pyrimidines; Quinuclidines; Tumor Suppressor Protein p53

2015